Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1500 participants
OBSERVATIONAL
2015-10-31
2020-04-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Minimum Concentration of Tranexamic Acid Required to Inhibit Fibrinolysis in a Population of Pregnant Women at Term.
NCT02579941
Risk Factors, Management and Complications of Severe Post-partum Hemorrhage
NCT02815605
Prophylactic Tranexamic Acid To Reduce Blood Loss During Caesarean Delivery.
NCT06604325
Thromboelastometry Guided DIC Prevention After Cesarean Section in Pregnant Women With Placenta Previa
NCT03266432
Patient Blood Management - Use and Outcome
NCT02473666
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PPH
blood exam
laboratory test
non-PPH
blood exam
laboratory test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood exam
laboratory test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian Haslinger, M.D.
Role: PRINCIPAL_INVESTIGATOR
Division of Obstetrics, University Hospital of Zurich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Zurich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KEK-ZH-Nr. 2015-0011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.